Aberrant expression of SRSF1 has been reported in various types of tumors, leading to abnormal RNA splicing, which in turn promotes the proliferation, migration and apoptosis resistance of tumor cells [5, 15, 16, 24]. The gene discussed is SRSF1; the disease is neoplasm.